Research is the best hope for finding a cure. This is why in 2018, the SRF launched CONQUER (COllaborative, National QUality and Efficacy Registry), a first-of-its-kind nationwide, longitudinal registry of...
Read More
If you missed our most recent webinar, don't worry—you can now watch it online. Learn more about GI involvement in systemic sclerosis in a webinar presented by SRF-funded researcher Dr....
Read More
Want to learn more about how research can help scleroderma patients with gastrointestinal complications? SRF-funded researcher Dr. Zsuzsanna McMahan, Assistant Professor of Medicine in the Division of Rheumatology at Johns...
Read More
SRF researchers Michael Longaker, MD, MBA, and Howard Chang, MD, PhD, both of Stanford University, recently published a paper in PNAS on their newly-developed integrated spatial multi-omic analysis platform, which they used to understand...
Read More
The SRF launched the CONQUER Registry in 2018 through a collaborative effort with the largest scleroderma centers in the U.S. The goal of this registry is the enrollment of thousands...
Read More
For Pulmonary Hypertension Awareness Month, we asked Scleroderma Research Foundation (SRF) board member Bob Smith his thoughts on the need for additional therapies for treating scleroderma-associated pulmonary arterial hypertension (PAH). “We...
Read More
At the American College of Rheumatology (ACR) meeting, SRF-funded investigator Dr. Kathryn Torok presented on the use of Autologous Stem Cell Transplantation (ASCT) for Treatment-Resistant Juvenile-Onset Systemic Sclerosis. The results...
Read More
The American College of Rheumatology meeting is in progress! Meet Dr. Elana Bernstein, an Assistant Professor at Columbia and Program Director of the CUMC/NYP Scleroderma Program, who studies lung disease in systemic...
Read More
The SRF's Scientific Advisory Board member, Daniel Kastner, MD, PhD, shares his approach to deepening the understanding of autoinflammatory diseases in a story published in the journal, "Science". "Autoinflammatory diseases...
Read More
We're pleased to announce a new SRF-funded research study: Establishing a Spatially–integrated Transcriptomic, Epigenomic, and Histologic Signature of Fibrosis in Systemic Sclerosis, led by Michael Longaker, MD, and Howard Chang,...
Read More
